Final Rule: Medication Assisted Treatment For Opioid Use Disorders

On July 8, 2016, the federal Department of Health and Human Services released this final rule regarding treatment for opioid use disorders. This final rule increases access to medication-assisted treatment with buprenorphine and the combination buprenorphine/naloxone in the office-based setting as authorized under the United States Code. This final rule is effective on August 8, 2016 . . .